Newsletters Biopharma

pharma news - Biopharma Insights


To download the current issue of  HIT Perpectives Biopharma Insights via PDF, please click the thumbnail image to the right.

Subscribe Now


HIT Perspectives (September 2020) PDF Download

Achieving Patient-Specific Price Transparency by Unlocking EHR Data | Tapping Pharmacy Infrastructure and Clinical Services in a Changing World | Pulling Back the Covers on Health Information Exchanges: Part 1

HIT Perspectives (June 2020) –  PDF Download

Innovations in Formulary, Benefit and Eligibility To Transform the Point of Care Experience | Four Factors Driving the Momentum of Telehealth Adoption That Will Continue After the COVID-19 Crisis | Post COVID-19: Five Things That Will Come Roaring Back With a Twist

HIT Perspectives (May 2020) –  PDF Download

The Critical Role of Health IT in Fighting COVID-19 Five Predictions on How the COVID-19 Crisis Will Transform Health IT  | Take Note of the Health IT Opportunities Emerging From the Final Interoperability Rules of ONC and CMS

HIT Perspectives (February 2020) –  PDF Download

Top 2020 Health IT Predictions: Opportunities Abound | How  Payers  and Providers Can  Succeed in Value-Based Care  | FAST: The Coalition Aiming to Strengthen the FHIR Interoperability Infrastructure


HIT Perspectives (December 2019) –  PDF Download

Four Reasons to Become a FHIRmacy | Five Key Ingredients for Successful Multistakeholder Initiatives | Digital Therapeutics: Transforming Care Through Technology

HIT Perspectives Biopharma Insights (September 2019)  – PDF Download

Three Essential Trends to Include in Q4 Planning  |  Lack of Training is Core Cause of Physician EHR Usability Complaints  |  ePA 2.0: Taking Electronic Prior Authorization to the Next Level


HIT Perspectives Biopharma Insights (November 2018)  – PDF Download

New Federal Opioid Legislation Has Potential Impacts for All Pharmaceuticals Connecting Patients With the Costs of their Medications

HIT Perspectives Biopharma Insights (September 2018)  – PDF Download

Automation of Specialty Pharmacy Gains Momentum  | Six Interoperability Trends to Watch  | Improving Drug Price Transparency: Progress and Opportunities

HIT Perspectives Biopharma Insights (June 2018)  – PDF Download

How Account Teams Can Help Ambulatory Physicians Succeed in the Era of Value-Based Care |Improving Drug Price Transparency: The Case for Out-of-Pocket Drug Cost Information at the Point of Prescribing | Thumbs Up at this ePrescribing Checkpoint!

HIT Perspectives Biopharma Insights (April 2018)  – PDF Download

Apple’s New App for Personal Health Information: Is It a Game Changer? | 10 Takeaways from HIMSS | The Da Vinci Project: Helping Payers and Providers Get the Most From Value-Based Care

HIT Perspectives Biopharma Insights (February 2018)  – PDF Download

Drug Benefit Cost Information at the Point of ePrescribing: What Lies Ahead | Top Trends to Watch in 2018 | Virtual Visits: Now Coming to Homes, Doctors and Pharmacies


HIT Perspectives Biopharma Insights (November  2017)  –  PDF Download

Following What the Doctor Ordered: Addressing Medication Noncompliance  | The Impact of New, Nonproprietary Naming Convention for Biologics and Biosimilars: 7 Key Findings | ONC  to Significantly Scale Back EHR Certification and Enrollment

HIT Perspectives Biopharma Insights (September  2017)  –  PDF Download

The Electronic Health Record: A Valuable Tool for Brand Teams | Interoperability and Standards Will Be Areas of Focus Through Year End  | Automating Enrollment for Specialty Prescriptions

HIT Perspectives Biopharma Insights (June 2017)  –  PDF Download

Why Population Health Management Should Matter to Pharmaceutical Manufacturers | HHS Moves Ahead in Personnel and Health IT | New Maturity Model Will Help Spur Adoption of Electronic Prior Authorization

HIT Perspectives Biopharma Insights (April 2017)  –  PDF Download

Eight Takeaways from HIMSS 2017 | FHIR Sets the Stage for Targeted Applications for Payers and Providers | Stakeholder Impacts of the AMA’s Prior Authorization Reform Proposal

HIT Perspectives Biopharma Insights (February 2017)  – PDF Download

10 Trends to Watch in 2017 | Will MACRA Be in the Crosshairs for Repeal and Replacement? | What the 21st Century Cures Act Means for Health IT


HIT Perspectives Biopharma Insights (November 2016)  – PDF Download

Working Smarter, Not Harder: Helping Clinicians Optimize Use of EHRs | Computerized Order Sets Help Physicians Save Time and Improve  Care | Electronic Dosing Instructions: Opportunities for Sales Teams

HIT Perspectives Biopharma Insights (September 2016)  – PDF Download

EHRs: A New Dissemination Tool for Patient Education Materials | Surescripts Issues its 2015 National Progress Report | Electronic Prior Authorization: Just What the Doctor Ordered (Almost)

HIT Perspectives Biopharma Insights (June 2016)  – PDF Download

New Proposed Regulation Rebrands and Retools Meaningful Use | Cutting Through the Confusion Surrounding Electronic Formulary and Benefit Checks | Retail Medical Clinics: Untapped Resources for Patient Education

HIT Perspectives Biopharma Insights (April 2016)  PDF Download

Ten Takeaways from HIMSS16 | Integrating EHRs and PDMPs: How Vendors Can Get Ahead of the Curve | Alerting Prescribers for Biosimilar Substitution to Protect Patient Safety

HIT Perspectives Biopharma Insights (February 2016) PDF Download

Top Ten Health IT Trends for 2016 | Getting Doctors Ready for New York’s War on Opioid Abuse | Meaningful Use: Not Entirely Gone but Certainly Not Forgotten


HIT Perspectives Biopharma Insights (November 2015)  – PDF Download

EHRS Can Expand the Quality and Scope of Physician Practices | Physicians’ Health, IT Priorities to Focus on ICD-10 and Meaningful Use | Why Care About the EHR Interoperability Brouhaha?

HIT Perspectives Biopharma Insights (September 2015)   –  PDF Download

Five Ways Pharmaceutical Companies Can Leverage EHR Market Changes and Challenges | Better Formulary and Benefit Information Pay Off for Payers | FDA to Assess Role for EHRs in Clinical Trials

HIT Perspectives Biopharma Insights (June 2015)  PDF Download

Surescripts Issues 2014 National Progress Report | Real-Time Benefit Check: Coming to the Point of Care | Efforts Under Way to Make REMS More Efficient and Less Burdensome

HIT Perspectives Biopharma Insights (May 2015) PDF Download

HIMSS15: On FHIR and 6 Other Key Takeaways | Meaningful Use Stage 3 Creates Opportunities for Pharma | The Impact of MU Stage 3 on Patient Engagement

HIT Perspectives Biopharma Insights (February 2015)  PDF Download

Exciting Changes Ahead in 2015 for HealthIT | New York Leads Way in Electronic War Against Opiod Abuse | EHRs: A Tool to Improve Vaccine Use


HIT Perspectives Biopharma Insights (December 2014)  – PDF Download

Biosimilars: Opportunity Knocks – Building a Better Technology Mousetrap | Improved Prescription Information: The Key to Closing the Medication Adherence Gap | Drug Databases: A Growing Resource for Patient Care and Safety

HIT Perspectives Biopharma Insights (September 2014)  PDF Download

What’s Next for EHR Market Consolidation? | Growing Use of Oral Specialty Medications to Spur ePrescribing Adoption | Real-World Evidence Comes to Mainstream Health Care

HIT Perspectives Biopharma Insights (July 2014)  –  PDF Download

Meaningful Use Learnings for Pharmaceutical Companies | Deciphering the Mystery of Population Health Management |Surescripts Stats Show ePrescribing Rounds Third Base

HIT Perspectives Biopharma Insights (April 2014) PDF Download

Guidelines and Best Practices: Ripe for an Assist from Managed Markets Teams | What’s Next for Meaningful Use? | Improving Adoption of Clinical Decision Support

HIT Perspectives Biopharma Insights (March 2014) – PDF Download

Improving ePrescribing as an Important Tool for Managed Markets | The Top Ten Health IT Trends for 2014 | Accelerating ePrescribing for Controlled Substances